Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -58.55% is 38% below its 5-year average of -42.31%, around the middle of its 5-year range (-125.00%–-15.83%).
As of the fiscal period ended Tuesday, June 30, 2026. 22.01% below its 12-month average of -47.99%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -58.55%.
RETURN ON INVESTED CAPITAL (ROIC)
-58.55%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-47.99%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-42.40%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-42.31%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-42.12%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-22.01%
CURRENT VS 3Y AVG
-38.10%
CURRENT VS 5Y AVG
-38.38%
CURRENT VS 10Y AVG
-39.01%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.80%
median of 696 covered companies
CURRENT VS SECTOR MEDIAN
-73.24%
vs the sector median at left
MediWound Ltd.
Market Cap
$171.75M
Return on Invested Capital (ROIC)
-58.55%
TTM Avg
-47.99%
3Y Avg
-42.40%
5Y Avg
-42.31%
Market Cap
$172.07M
Return on Invested Capital (ROIC)
-42.11%
TTM Avg
-29.16%
3Y Avg
-30.37%
5Y Avg
-28.38%
Market Cap
$172.75M
Return on Invested Capital (ROIC)
-1039.56%
TTM Avg
-137.05%
3Y Avg
-111.74%
5Y Avg
-93.55%
Market Cap
$173.23M
Return on Invested Capital (ROIC)
-42.61%
TTM Avg
-32.20%
3Y Avg
-32.84%
5Y Avg
-32.70%
Market Cap
$169.21M
Return on Invested Capital (ROIC)
-8.34%
TTM Avg
4.10%
3Y Avg
3.63%
5Y Avg
7.54%
Market Cap
$173.75M
Return on Invested Capital (ROIC)
-30.23%
TTM Avg
-28.70%
3Y Avg
-31.34%
5Y Avg
-41.69%
Market Cap
$167.20M
Return on Invested Capital (ROIC)
4.92%
TTM Avg
-1.65%
3Y Avg
-7.20%
5Y Avg
-5.46%
Market Cap
$176.86M
Return on Invested Capital (ROIC)
-46.59%
TTM Avg
-39.23%
3Y Avg
-33.74%
5Y Avg
-53.74%
Market Cap
$165.58M
Return on Invested Capital (ROIC)
-49.08%
TTM Avg
-23.18%
3Y Avg
-21.02%
5Y Avg
-18.22%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MediWound Ltd. (MDWD) | $171.75M | -58.55% | -47.99% | -42.40% | -42.31% |
| Nkarta, Inc. (NKTX)vs › | $172.07M | -42.11% | -29.16% | -30.37% | -28.38% |
| Cue Biopharma, Inc. (CUE)vs › | $172.75M | -1039.56% | -137.05% | -111.74% | -93.55% |
| ProQR Therapeutics N.V. (PRQR)vs › | $173.23M | -42.61% | -32.20% | -32.84% | -32.70% |
| Organogenesis Holdings Inc. (ORGO)vs › | $169.21M | -8.34% | 4.10% | 3.63% | 7.54% |
| Precision BioSciences, Inc. (DTIL)vs › | $173.75M | -30.23% | -28.70% | -31.34% | -41.69% |
| OptimizeRx Corp. (OPRX)vs › | $167.20M | 4.92% | -1.65% | -7.20% | -5.46% |
| Compass Therapeutics, Inc. (CMPX)vs › | $176.86M | -46.59% | -39.23% | -33.74% | -53.74% |
| Quanterix Corporation (QTRX)vs › | $165.58M | -49.08% | -23.18% | -21.02% | -18.22% |
| Coherus Oncology, Inc. (CHRS)vs › | $164.54M | -135.38% | -110.80% | -91.23% | -65.73% |
ROIC
-58.6%
ROE
-56.6%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -58.55% |
| 2026-03-31 | -48.06% |
| 2025-12-31 | -41.75% |
| 2025-09-30 | -34.55% |
| 2025-06-30 | -57.04% |
| 2025-03-31 | -44.25% |
| 2024-12-31 | -41.28% |
| 2024-09-30 | -34.98% |
| 2024-06-30 | -41.84% |
| 2024-03-31 | -36.61% |
| 2023-12-31 | -27.49% |
| 2023-09-30 | -15.83% |
| 2023-06-30 | -17.41% |
| 2023-03-31 | -15.87% |
| 2022-12-31 | -21.98% |
| 2022-09-30 | -63.49% |
| 2022-06-30 | -125.00% |
| 2022-03-31 | -83.24% |
| 2021-12-31 | -124.36% |
| 2021-09-30 | -66.92% |
| 2021-06-30 | -52.86% |
| 2021-03-31 | -40.23% |
| 2020-12-31 | -38.77% |
| 2020-09-30 | -40.51% |
| 2020-06-30 | -43.40% |
| 2020-03-31 | 21.63% |
| 2019-12-31 | 14.87% |
| 2019-09-30 | 38.55% |
| 2019-06-30 | 34.34% |
| 2019-03-31 | -13.99% |
| 2018-12-31 | -13.04% |
| 2018-09-30 | -44.21% |
| 2018-06-30 | -42.86% |
| 2018-03-31 | -39.81% |
| 2017-12-31 | -35.37% |
| 2017-09-30 | -40.71% |
| 2017-06-30 | -72.85% |
| 2017-03-31 | -74.66% |
| 2016-12-31 | -66.33% |
| 2016-09-30 | -64.33% |
| 2016-06-30 | -56.22% |
| 2016-03-31 | -47.49% |
| 2015-12-31 | -44.86% |
| 2015-09-30 | -40.01% |
| 2015-06-30 | -38.04% |
| 2015-03-31 | -34.74% |
| 2014-12-31 | -31.87% |
| 2014-09-30 | -23.37% |
| 2014-06-30 | -18.28% |
| 2014-03-31 | -13.11% |
| 2013-12-31 | -59.21% |
| 2013-09-30 | -40.14% |
